K-ras and B-raf mutations and anti-EGFr antibody therapy

DOI:

关键词:

摘要: The present application relates to K-ras mutations, polynucleotides encoding mutant polypeptides, and methods of identifying mutations. also B-raf vectors containing those polynucleotides, diagnosing cancer; kits for predicting the usefulness anti-EGFr specific binding agents in treatment tumors.

参考文章(32)

Fritz Eckstein, Oligonucleotides and analogues : a practical approach IRL Press : Oxford University Press, c1991. ,(1991)

Elvin A. Kabat, Sequences of proteins of immunological interest National Institutes of Health. ,(1991)

Carl Ivar Branden, John Tooze, Introduction to protein structure ,(1991)

Jeanne Harvey, Sharat Singh, Bruce Neri, Methods of predicting and monitoring tyrosine kinase inhibitor therapy ,(2007)

Alberto Bardelli, Salvatore Siena, Mauro Moroni, Epidermal growth factor receptor gene copy number ,(2006)

Giovanna Marrapese, Silvio Veronese, Alberto Bardelli, Andrea Sartore-Bianchi, Salvatore Siena, Nicolantonio Federica Di, Silvia Benvenuti, Marcello Gambacorta, Mauro Moroni, Anti-egfr antibody therapy based on an increased copy number of the egfr gene in tumor tissues ,(2006)

Michele A. Benish, Raymond J. A. Budde, Michael Lawless, Thienopyrimidine-based inhibitors of the src family ,(2001)

Xiao-Dong Yang, Gisela Schwab, Treatment of renal carcinoma using antibodies against the EGFr ,(2003)

Kenneth J. Hillan, Egfr and kras mutations ,(2006)

10.

B. John Bergot, Bernard L. Hirschbein, Karen L. Fearon, Wojciech J. Stec, Bogdan Uznanski, Method of synthesizing sulfurized oligonucleotide analogs ,(1991)

K-ras and B-raf mutations and anti-EGFr antibody therapy

来源期刊

我的账户

K-ras and B-raf mutations and anti-EGFr antibody therapy

来源期刊

相似文章 10

我的账户